PA
FLNA

Profund Advisors’s Filana Therapeutics FLNA Stock Holding History

Profund Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,792
Closed -$406K – 1177
2024
Q3 		$406K Buy
13,792
+352
+3% +$8.11K 0.02% 626
2024
Q2 		$166K Buy
13,440
+591
+5% +$12.5K 0.01% 1011
2024
Q1 		$261K Buy
12,849
+1,099
+9% +$25.3K 0.01% 933
2023
Q4 		$264K Sell
11,750
-2,033
-15% -$42.9K 0.01% 854
2023
Q3 		$229K Buy
13,783
+4,385
+47% +$86.9K 0.01% 797
2023
Q2 		$230K Sell
9,398
-11,565
-55% -$279K 0.01% 882
2023
Q1 		$506K Buy
+20,963
New +$581K 0.03% 499

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Profund Advisors's FLNA Position: Q4 2024 in Review

Profund Advisors sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 13,792 shares — an estimated $406K sold.

Profund Advisors first reported a position in FLNA in Q1 2023 and held it in 7 quarters. The position peaked at $506K in Q1 2023. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Profund Advisors reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Profund Advisors sold 13,792 Filana Therapeutics shares in Q4 2024, an estimated $406K.
  • Profund Advisors first reported a position in Filana Therapeutics in Q1 2023 and held it in 7 quarters.
  • Profund Advisors's Filana Therapeutics position peaked at $506K in Q1 2023.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Profund Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.